|
NCD-LIFESPAN GLOBAL MENTAL HEALTH/DEVELOPMENTAL DISORDERS RESEARCH TRAINING INITI |
3D43TW009680-03S1 |
MUNIR, KERIM M |
FIC |
2016 |
|
NCD-LIFESPAN GLOBAL MENTAL HEALTH/DEVELOPMENTAL DISORDERS RESEARCH TRAINING INITI |
5D43TW009680-03 |
MUNIR, KERIM M |
FIC |
2016 |
|
LUM-001 AS A TREATMENT FOR CREATINE TRANSPORTER DEFICIENCY |
1ZIATR000006-02 |
OTTINGER, ELIZABETH |
NCATS |
2016 |
|
PRE-CLINICAL DEVELOPMENT OF EDN-OL1 FOR ALZHEIMER'S DISEASE |
1ZIATR000022-02 |
XU, XIN |
NCATS |
2016 |
|
A DRUG-SCREENING PLATFORM FOR AUTISM SPECTRUM DISORDERS USING HUMAN NEURONS AND ASTROCYTES |
1ZIATR000073-02 |
FERRER, MARC |
NCATS |
2016 |
|
A DRUG BASED APPROACH FOR INTEGRIN-MEDIATED ALLEVIATION FOR MUSCULAR DYSTROPHY |
1ZIATR000229-02 |
MARUGAN, JUAN |
NCATS |
2016 |
|
OPTIMIZATION AND NORMALIZATION STUDIES FOR INDIVIDUAL CSF SAMPLES |
3UH3TR000903-04S1 |
SAUGSTAD, JULIE ANNE |
NCATS |
2016 |
|
CLINICAL UTILITY OF MICRORNAS AS DIAGNOSTIC BIOMARKERS OF ALZHEIMER'S DISEASE |
5UH3TR000903-04 |
SAUGSTAD, JULIE ANNE |
NCATS |
2016 |
|
THERAPEUTIC STRATEGY FOR LAM (LYMPHANGIOLEIOMYOMATOSIS) |
5UH3TR000961-03 |
EISSA, N. TONY |
NCATS |
2016 |
|
CALCINEURIN-NFAT REGULATES ENDOTHELIAL ACTIVATION IN PRE-METASTATIC SITES |
3R01CA118374-08S1 |
RYEOM, SANDRA W. |
NCI |
2016 |